Advertisement

Topics

Oxford Immunotec Schedules First Quarter 2018 Earnings Release and Conference Call for May 1, 2018

10:30 EDT 17 Apr 2018 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
OXFORD, United Kingdom and MARLBOROUGH, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it plans to release first quarter 2018 financial results prio...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Oxford Immunotec Schedules First Quarter 2018 Earnings Release and Conference Call for May 1, 2018"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Tuberculosis TB
Tuberculosis (TB) is an infectious disease caused by bacteria belonging to the Mycobacterium tuberculosis complex. Over nine million new cases of TB, and nearly two million deaths from TB, are estimated to occur around the world every year, and new inf...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...